S&P 500
7,479.80
+0.40%
Dow Jones
52,055.90
+0.26%
Nasdaq 100
28,884.50
+0.90%
Russell 2000
2,957.67
+0.49%
FTSE 100
10,470.00
+0.06%
Nikkei 225
65,841.20
+1.14%

Personal Finance

DCPH logo Deciphera Pharmaceuticals Inc : DCPH

DCPH

Stock Data

$25.59

Change up

$0.00 (0.00%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - SPECIALTY & GENERIC

Deciphera Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative drugs to improve the lives of cancer patients. With a keen eye on overcoming drug resistance, its flagship product, QINLOCK, is designed for treating gastrointestinal stromal tumors. The company is also working on vimseltinib for tenosynovial giant cell tumor and DCC-3116 for RAS/RAF mutant cancers. Founded in 2003 and based in Waltham, Massachusetts, Deciphera is committed to advancing cancer treatment options worldwide.

All DCPH Articles

0 Articles

No articles found for DCPH.